Dracen Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.dracenpharma.com
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study to Investigate DRP-104 in Adults With Advanced Solid Tumors
Phase 1
Terminated
- Conditions
- Advanced Solid TumorNon Small Cell Lung Cancer Metastatic
- Interventions
- Biological: atezolizumab
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2023-06-12
- Lead Sponsor
- Dracen Pharmaceuticals, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT04471415
- Locations
- 🇺🇸
HonorHealth, Scottsdale, Arizona, United States
🇺🇸UCLA, Los Angeles, California, United States
🇺🇸AdventHealth Medical Group, Kissimmee, Florida, United States
News
No news found